Sort by
Refine Your Search
-
autoimmunity. The overarching goal of the Wu lab is to harness innate immunity to develop new immunotherapies for cancer and inflammatory diseases. Our recent research has been published in top-tier journals
-
Imperial College Research Fellowship £48,056 - £56,345 per annum About the role: Imperial College London is promoting our exciting opportunity for outstanding early career researchers to develop
-
and cancer. Ultimately, we aim to mitigate the pathogenesis and develop treatments for chronic metabolic diseases. We have established unique, comprehensive mouse models for: 1) real-time labeling and
-
to intervene the malignancies 3) collaborative analyses of myeloid cancers genomics using high-throughput single-cell sequencing chor high throughput proteomics 4) development of small molecule drugs and PROTAC
-
regulation and other aspects of cellular signal transduction. We use our structural and mechanistic insights to drive development of novel anti-cancer drugs. Systems of current interest in the lab include RAF
-
multiomics, high-throughput sequencing projects and help develop any projects based on the most advanced technologies. Your qualifications should include: Ph.D. in Biochemistry, Bioinformatics, Genomics, or a
-
development of innovative therapeutic strategies. Located in Boston and the surrounding communities, Dana-Farber Cancer Institute is a leader in life changing breakthroughs in cancer research and patient care
-
lung and other malignancies, affording access to patient samples and large tumor databases. Specific research areas of interest include development of optimized strategies for efficient and specific
-
to promote public health particularly among high-risk and underserved populations. We conduct groundbreaking research that advances treatment, we educate tomorrow's physician/researchers, and we work with
-
and underserved populations. We conduct groundbreaking research that advances treatment, we educate tomorrow's physician/researchers, and we work with amazing partners, including other Harvard Medical